Use of decompressive craniectomy in the treatment of hemispheric infarction

Decompressive craniectomy (DC) has demonstrated efficacy in reducing mortality in hemispheric infarction of the middle cerebral artery. The aim of our study was to compare the outcome of patients submitted to DC to patients treated in a conservative way. Eighteen patients were submitted to DC and 14 received conservative treatment. Neurological status was assessed by the Glasgow Coma Score and National Institutes of Health Stroke Scale score. Mortality, modified Rankin Scale and Barthel Index scores were assessed at 90 days to evaluate outcome. We did not observe reduction in overall mortality and functional outcome in patients submitted to DC. The differences between our group and previously published series are probably related to the neurological status of the patients at the time of therapeutic decision.

Saved in:
Bibliographic Details
Main Authors: Fiorot Jr.,José Antonio, Silva,Gisele Sampaio, Cavalheiro,Sergio, Massaro,Ayrton Roberto
Format: Digital revista
Language:English
Published: Academia Brasileira de Neurologia - ABNEURO 2008
Online Access:http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2008000200012
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Decompressive craniectomy (DC) has demonstrated efficacy in reducing mortality in hemispheric infarction of the middle cerebral artery. The aim of our study was to compare the outcome of patients submitted to DC to patients treated in a conservative way. Eighteen patients were submitted to DC and 14 received conservative treatment. Neurological status was assessed by the Glasgow Coma Score and National Institutes of Health Stroke Scale score. Mortality, modified Rankin Scale and Barthel Index scores were assessed at 90 days to evaluate outcome. We did not observe reduction in overall mortality and functional outcome in patients submitted to DC. The differences between our group and previously published series are probably related to the neurological status of the patients at the time of therapeutic decision.